At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
In Brief
A clinical study evaluating Laboratory Biomarker Analysis, Screening Questionnaire Administration, and 1 other intervention for Ovarian Carcinoma and Ovarian Germ Cell Tumor. Active but no longer recruiting, targeting 78,216 participants across 1 site.
Detailed Summary
This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for ovarian cancer. The ovarian cancer screening tests are part of a trial that addresses the screening of four cancer sites, each with their own results record: prostate (NCT00002540), lung (NCT01696968), colorectal (NCT01696981), and ovarian (NCT01696994).
Study Details
Timeline
Interventions
Correlative studies
Undergo questionnaire assessments
Undergo TVU